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This chapter presents the overall findings from the study and reports on the four 
broad themes, namely i) searching; ii) suffering in silence; iii) trying to resolve and; 
iv) accepting what is. The themes provide insight into the different strategies used by 
women to cope with the sexual side effects of SSRI medication and h a v e  
p r a c t i c a l  i mp l i c a t i o n s  f o r  wo me n  o n  S S R I s  a n d  f o r  clinicians, 
therapists and other relevant health professionals. The findings highlight the 
importance of contextualising these difficulties as part of an overall approach to 



















A growing body of evidence has highlighted the sexual side effects of 
selective serotonin reuptake inhibitor (SSRI) medication. Whilst most of the 
research has focused on the prevalence and treatment of sexual difficulties, 
little is known about how individuals cope with the SSRI related sexual side 
effects. The objective of this study was to explore women’s experiences of 
coping with the sexual side effects of SSRI medication and interpretative 
phenomenological analysis (IPA) was employed for an in-depth exploratory 
study of a sample of ten women. Four broad themes emerged which are 
discussed under the following headings: searching, suffering in silence, trying 
to resolve and accepting what is. The themes provide an insight into the 
different strategies used by women to cope with the sexual side effects of 
SSRI medication and highlight the importance of contextualising these 
difficulties as part of an overall approach to improve the management and 
treatment of SSRI related sexual side effects. 
 
















Depression is a leading contributor to the non-fatal burden of disease, and evidence 
suggests antidepressant drug use is increasing in developed countries (Saragoussi 
et al., 2012; Zhang et al., 2010).  Although a variety of antidepressants are available, 
including tricyclics (TCAs), and monoamine oxidase inhibitors (MAOIs), selective 
serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed 
antidepressant in Australia (Wong, Taylor, Ashby & Robinson, 2010).  This paper 
focuses on the side effects of SSRIs including fluoxetine (Prozac), paroxetine 
(Aropax/Paxil), sertraline (Zoloft), citalopram (Celexa), escitalopram (Lexapro) and 
fluvoaxamine (Luvox). SSRIs differ from older antidepressants in their chemical 
structure and method of action; the side effects of this newer medication are more 
tolerable making these a first line treatment for depression and anxiety (Moret, 
Issacc & Briley, 2009). Whilst SSRIs are generally well tolerated, they are not devoid 
of side effects. Several authors have reported on treatment emergent sexual side 
effects and state how these adverse side effects are a common cause for non-
adherence to long- term treatment (Basson, Rees, Wang, Montejo &Incrocci, 2010; 
Serretti & Chiesa, 2009). Widespread use of SSRIs and concerns relating to 
adherence rates have prompted an emerging body of research into the sexual side 
effects (Basson et al., 2010; Grover et al., 2012) and have been the focus of a recent 
Cochrane review (Taylor et al., 2013).  
As sexual difficulties may occur for a number of reasons, it remains difficult to 
obtain statistics relating to the prevalence of treatment emergent sexual difficulties 
resulting from this medication (Clayton & Balon, 2009; Safarinejad, 2011). What is 
becoming evident, however, is that sexual side effects are more common than 
initially perceived.  Studies have reported treatment emergent sexual side effects of 
over 50% (Fisher & Thomson, 2006; Grover et al., 2012; Serretti & Chiesa, 2009). 
According to Basson et al. (2010), side effects were related to all aspects of sexual 
functioning but the main effects were loss of desire and delay of orgasm. As women 
are at increased risk of mental health problems, and have higher levels of  SSRI use 
(Hollingworth, Burgess & Whiteford, 2010; Zhang et al., 2010), recent studies have 
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focused specifically on the treatment of SSRI related sexual difficulties in women in 
an attempt to improve quality of life and to increase adherence to medication 
(Demmyttenaere & Jaspers, 2008; Safarinejad, 2011). To date, treatment and 
management approaches have included a number of strategies including drug 
holidays, natural supplements, switching antidepressants and augmenting 
antidepressant treatment with other medications including buproprion and sildenafil 
(Nurnberg et al., 2008; Safarinejad, 2011). In the Cochrane review undertaken in 
2013, 23 randomised studies focused on managing sexual difficulties associated 
with antidepressant use were reviewed (Taylor et al., 2013). Twenty-two of these 
studies investigated the addition of further medication to treat sexual difficulties and 
one study investigated switching to an alternative antidepressant. According to this 
report, augmenting antidepressant treatment with buproprion at high levels appeared 
to be the most promising strategy for treating women, however, the authors called for 
more evidence to guide the management and treatment of sexual difficulties (Taylor 
et al., 2013). 
Numerous scholars have critiqued the biomedical approach to sexuality 
research (Farrell & Cacchioni, 2012; Moynihan, 2003; Tiefer, 2012), yet this 
approach has dominated most of the research into SSRI related sexual difficulties 
(Safarinejad, 2011; Taylor et al., 2013; Williams et al., 2010). One major criticism of 
this approach is that it fails to consider the social and cultural construction of sexual 
experience. Dworkin and O’Sullivan (2007, p.106), revealed how traditional sexual 
scripts in Western culture which offer men ‘greater sexual freedom and rights of 
sexual determination’ than women, can affect sexual experiences and interactions. 
Weiderman’s (2005) article, relating to male and female sexual scripts in Western 
culture, highlighted how women have felt pressured to follow traditional sexual 
scripts, adjusting their behaviour to meet cultural and social norms. Another limitation 
of the biomedical approach, according to Bahrick and Harris (2009, p.136), was that 
psychosocial aspects of antidepressant related sexual difficulties have been largely 
ignored; little is known about how the addition of sexual difficulties may potentially 
‘complicate and confuse the clinical picture, exacerbate client distress and 
destabilise intimate relationships.’ From the literature review, it became obvious that 
investigating women’s subjective experiences of coping with SSRI related sexual 
difficulties was necessary. As such, the focus of this research was on the coping 
aspect of heterosexual women’s experiences and the research question was, “What 
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are the lived experiences of coping with the sexual side effects of SSRI medication?” 
The findings from this research provide further insight into the types of strategies that 
may be relevant for women on antidepressant medication and for clinicians, 
therapists and other health professionals, in order to improve the success of and 
satisfaction with SSRI treatment. 
 In this study, the term ‘sexual difficulty’ was used.  A definition was not 
provided as each participant brought her own understanding and identification of 
what sexual difficulty meant to her. Whilst female sexual difficulties relating to desire, 
arousal, orgasm and pain are currently grouped under the term ‘sexual dysfunction’ 
in the most recent Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5R) (American Psychiatric Association, 2013), sexual dysfunction is a 
contested term which aligns with a medicalised view of sexual difficulties. This 
approach has been criticised for pathologising women and often disregarding the 





The study used Interpretative Phenomenological Analysis (IPA) as a research 
approach. Three key areas of philosophy of knowledge namely, ‘phenomenology, 
hermeneutics and idiography’ have informed this approach (Smith, Flowers and 
Larkin, 2009). IPA has been used for over a decade to capture women’s experiences 
of intimate topics relating to their sexual health (Holt & Slade, 2003; Lavie & Willig, 
2005; Marriott & Thompson, 2008) and was therefore particularly suited to this study 
as it captured the unique voices and experiences of women and situated those 
experiences within a social and cultural context.  
 
Sampling 
The intention was to recruit a purposive sample – that is, using criteria 
relevant to the research question, rather than necessarily being representative of the 
population living with SSRI related sexual difficulties. Whilst recognising that it is 
difficult to ensure complete homogeneity, especially with respect to factors such as 
relationship dynamics, a degree of homogeneity was sought by recruiting potential 
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participants through the application of inclusion criteria.  This criteria included the 
following  i) Australian females under 45 years old who were currently in a 
heterosexual relationship and who had been taking SSRIs for longer than 3 months; 
ii) females who self described as experiencing sexual difficulties that were believed 
to be attributable to SSRIs; iii) females who were experiencing sexual difficulties that 
were causing problems or distress to her and/or her partner. The authors selected 45 
years as the appropriate cut off for this study as prevalence and treatment rates of 
affective and anxiety disorders decline rapidly after this age (Hollingworth, Burgess & 
Whiteford, 2010).  
Participants for this study were recruited via a mental health website 
(depressionnet.com), social media sites and snowball techniques (Liamputtong, 
2013). As reported by Moreira, Glasser, King, Duarte and Gingell (2008) and Shifren 
et al. (2009), women have often been reluctant to seek help for sexual problems, 
therefore, we did not recruit through health professionals or clinics. Interested women 
were emailed a brief questionnaire to capture demographic information and to ensure 
inclusion criteria were met. Those who met the inclusion criteria (ten women), were 
invited to participate in the study. 
Whilst no definitive criteria exist for sample size in IPA, its commitment to an 
idiographic approach results in such studies generally being conducted with  small 
sample sizes of ten or less (Smith et al., 2009). The authors perceived that the 
sample of ten women adequately captured patterns of similarity within the group 
whilst recognising the particularities of individual lives. 
  
 Data Collection 
Prior to data collection, ethical approval was obtained from the relevant 
university human research ethics committee. Data were collected through two semi-
structured interviews comprised of questions that related to heterosexual women’s 
experiences of coping with the sexual side effects of SSRI medication. The interview 
schedule comprised of eight open-ended questions, which were informed by the 
literature review and professional experience of the first author. Informed consent was 
obtained from each woman prior to the first interview. First interviews were face-to-
face and lasted between 1 hour and 1 hour 45 minutes in length. Follow up interviews 
were between 45 minutes and 1 hour 15 minutes. During this second interview, the 
lead researcher and each woman reviewed the transcript and discussed emergent 
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themes arising from the first interview to ensure accurate interpretation of the 
participant’s experience. In addition, women were given the opportunity to further 
elaborate on their lived experiences; this led to enriched data as women had been 
given an opportunity to reflect on their experiences after the first interview.  
 
Data Analysis 
Data analysis followed guidelines put forward by Smith et al. (2009), and 
involved the following: reading and re reading the transcript, initial noting, developing 
emergent themes, searching for connection across emergent themes, moving to the 
next case and looking for patterns across cases. As this research was interpretive, 
the lead researcher’s comments whilst analysing and noting emergent themes, 
moved beyond descriptive words and phrases to a deeper conceptual analysis to 
acknowledge social and cultural contexts.  Upon completion of analysis from both 
interviews, a description of the themes was given to each woman to check the 
interpretation. Once data analysis was completed for all cases, the next stage 
involved analysing for recurrent themes across all ten cases; this resulted in four 
super- ordinate themes. Eleven corresponding sub-ordinate themes were nested 
within these super-ordinate themes. The super and sub-ordinate themes are 
discussed under Findings. 
 
Reflexivity 
Within IPA, the researcher plays an active role in interpreting data. Smith et al. 
(2009) highlighted the importance of reflexivity (where the researcher reflects on how 
their experiences may influence the research). As the lead researcher had 
experienced the sexual side effects of SSRI medication, the experience meant that 
the interviewer was conducting the research from an insider emic perspective. She 
briefly touched upon her experiences of sexual difficulties with each woman at the 
beginning of the first interview while emphasising that the purpose of the study was 
to explore their individual stories and unique experience of coping. Women were 
given the opportunity to ask questions about the researcher’s experiences at the end 
of each interview.  
During data collection, the researcher utilised a reflexive journal to 
acknowledge her preconceptions and assumptions before and immediately after 
each interview.  By attempting to set aside her preconceptions immediately before 
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the interview, the researcher felt she was able to listen attentively to the participant’s 
story rather than being distracted by her own experiences. Smith et al. (2009) 
highlight the importance of attentive listening and engagement with the participant, 
and argue that such close attention during the interview process limits the influence 
of the researcher’s preconceptions. Throughout the data analysis phase, reflexive 
journaling enabled the researcher to reflect upon the data to ensure it reflected the 
experiences of women rather than her own prior to documenting conclusions. The 
researcher also obtained the support of a colleague who questioned whether 
assumptions had been made and highlighted potential areas of bias, which may 
have been influenced by the researcher’s history and perspective. 
 
Findings 
The following is an account of the lived experiences of women coping with the sexual 
side effects of SSRI medication. The four separate but overlapping super-ordinate 
themes and eleven sub-ordinate themes that emerged from the data analysis are 
supported with quotations from the women’s accounts. At various stages throughout 
their journey, women adopted one or more of the coping strategies and the 
combination of approaches used by the women tended to vary over time. 
Pseudonyms were assigned to protect each woman’s identity. 
Searching 
This theme describes the processes women engaged in as part of their 
coping mechanism when first experiencing what they identified as sexual difficulties 
associated with SSRI medication, and at times throughout their journey. The theme 
searching, included two sub-ordinate themes i) searching for answers and ii) 
searching for validation.  
 
Searching for answers 
A search for reasons behind the sexual side effects frequently underpinned the 
coping experience of most women in this study, with women commonly commenting 
on how GPs had neglected to inform them about the side effects when the 
medication was prescribed. Consequently, these women particularly struggled with 
sexual side effects at an early stage in their journey, and frequently questioned 
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whether they had psychological problems and/or whether their experiences were 
normal.  
 
I guess for me, finding that information [on the internet], that was a real 
turning point, I   finally had my answer. ......if you go back to the leaflet in the 
medication it says that you may experience side effects but there’s about 5 
million side effects on there. Initially I thought they’re just covering their back 
you know just in case, and I thought, well you know, reality is it’s probably 1 
in a million chance that you’re going to have sexual sides effects, and then I 
started reading about it and I thought... hang on a minute, the amount of 
women that are experiencing this is not one in a million, there are thousands 
of us. (Nadia, 42)   
The women talked about the difficulties of sharing their problems due to the 
perceived public stigma of mental illness, and the sensitive and emotive nature of 
their problem. As women were unable to communicate with friends or trusted others, 
information about their side effects was predominantly sought from the internet. By 
searching on the internet, women discovered sexual side effects were frequent 
amongst users of SSRIs. For these women, having a legitimate reason for their 
sexual difficulties and finding they were not alone with their experiences proved a 
positive turning point: 
Once I realised that the sensation wasn’t there, I started to freak out, I did 
actually quite freak out about for a while and then I think I Googled about 
possible female side effects, and I didn’t find much on it, but found something, 
there was something. I don’t know if there was a forum or something, where I 
kind of read about women not being able to reach orgasm. At the time, yeah I’m 
thinking relief, just relief that at least I knew why it was happening, it wasn’t just 
me, I wasn’t some kind of freak. (Mandy, 38)  
The primary motivation for searching for information stemmed from a desire to 
protect current relationships. Having answers about the sexual side effects had 




When I did eventually find the articles on the net, I would show him and say 
“Look it’s not just me, lots of women are going through this. It’s not your fault, it’s 
got nothing to do with you, it’s got nothing to do with our relationship” to help him 
understand. Because I guess you worry, you think well you know, they might 
think that I’m frigid or I’m not interested in them anymore. I guess I don’t want 
him having a complex.  (Tahlia, 26) 
The majority of women felt having more information at an earlier stage, would have 
assisted them in coping. Alison, who had received information from her general 
practitioner, talked about feeling prepared and her experiences highlighted the 
importance of knowing about the side effects in advance: 
I remembered exactly what she had told me um, so (pause) I guess to an 
extent it did help because you know I sort of had that awareness up front that 
this could be an issue.....when it actually came up as an issue I was kind of a 
bit more prepared for it. If she hadn’t even said those couple of sentences to 
me I would be thinking “What the hell is wrong? What’s going on? I don’t 
understand this at all?” um, and be pretty confronted and scared by that I 
guess. (Alison, 29) 
 
  
Searching for validation  
For the women, having their sexual concerns validated played an important part in 
helping them to cope. They felt the difficulties were serious enough to consider 
seeking professional help but their experiences of not having concerns validated by 
GPs had an impact on how they understood and hence coped with difficulties 
initially. Charlotte mentioned about ‘psyching herself’ to build the courage to raise the 
issue with her GP, her comment below typifies the dismissive comments and 
reactions experienced by the women in this study: 
 
When I eventually went to the Drs, it’s like "Oh you know, it's a typical women 
thing. You've got kids, life’s stressful deal with it". Well I've been through a lot 
more stress in my life and it didn't do that to my libido! I asked him if there was 
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a Viagra for women or something - he laughed and said he'll get back to me - 
that's 6 months ago and I'm still waiting. (Charlotte, 45) 
 
  Furthermore, women reported that GPs appeared unwilling to accept their 
sexual side effects as a legitimate problem. This led them to seek validation and 
support through online discussions forums. Nadia commented: 
But deep down I’ve always been really angry about that [GPs dismissing sexual 
concerns] and thought, “No that’s not quite right.” So I guess validating that and 
finding that other women on there [internet] also are saying you know “I haven’t 
got a good sex life and I want to do something about it” makes me feel better. 
(Nadia, 42) 
Suffering in Silence 
For the women in this study, the theme suffering in silence emerged as a coping 
strategy and captured the women’s sense of not being able to communicate about 
their experiences.  The sub-ordinate themes of avoiding sexual encounters, 
protecting one’s partner and protecting one’s self were often intertwined, but are 
discussed separately to enhance conceptual clarity.  
Avoiding sexual encounters. 
The women coped with sexual side effects by avoiding sexual encounters either 
through passive or proactive avoidance strategies. Whilst most women viewed this 
strategy as temporary, and recognised they were not adequately addressing the 
problem, Mandy considered this to be an appropriate strategy for a short term 
problem: 
Well my husband works away so I mean his last stint away was for four weeks 
and I really could not have been interested, it was the best time of my life 
(pause) because he wasn’t home annoying me about sex. If I could keep 





 Other women talked about the importance of not wanting to reject openly their 
partner’s advances; hence, a number of proactive avoidance strategies were used 
which enabled women to avoid sexual activity without actually saying ‘No’:  
I’d go to bed half an hour before him so I’d be asleep when he came in, or half 
an hour after so that he’d be asleep. Just so I could avoid sex in any way. 
(Charlotte, 45)  
One woman talked about avoiding all forms of intimate contact, fearing such 
encounters would automatically lead to sex:  
Sometimes I just feel like a kiss and cuddle, especially at night, but then I think 
"Am I leading him on?" 'cos I know I don't want sex. It's hard, I still want to be 
intimate but I'm scared because I know it will lead to other stuff. (Sonia, 30) 
Interestingly, the avoidance strategies put into place by the women, highlighted 
again, the separate but overlapping nature of sub-ordinate themes grouped under 
‘Suffering in Silence’. By adopting avoidance as a coping strategy, women 
succeeded in protecting their partners (from rejection) and protecting themselves 
(from an unwanted sexual experience). 
Protecting one’s partner. 
Having sex was perceived as being central to the women’s relationships in this 
study. Believing their partner would be upset if there was a sexual problem, many 
women were compelled to protect their partners and viewed the problem as their 
‘own problem’ as opposed to a shared problem. More than half of the women, 
predominantly those who had been taking medication for less than one year, made a 
conscious decision to cope with sexual difficulties alone. Most women held the view 
that they were obliged to have sex with their partners thereby placing his sexual 
needs as more important than their own: 
 I didn’t want to tell him, that when I was having sex with him I’d rather be 
sleeping. That would have just killed his ego. It would have been very 
detrimental to him. There was no way I could say that I’m just going through 
with this just for your benefit. (Helen, 23) 
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Women also talked about the need to reciprocate as part of a healthy relationship 
and to be sensitive to their partner’s needs: 
My husband is so wonderful and I feel so guilty that I don’t have a libido for him. 
I do feel obligated though, he’s so gentle and kind – sometimes after sex I just 
end up crying, but I manage to hide it - he’s my husband, I love him, so I let him 
do it. (Charlotte, 45) 
 
Faking orgasm was a common coping strategy to manage the potential relationship 
impact of the sexual side effects. Although many women talked about feeling guilty 
and even deceptive within their relationship, in contrast, one woman considered this 
to be an acceptable and effective strategy:   
It works well for our situation, I mean, you can fake sexual pleasure, but you 
can't fake the weight gain can you? (Mandy, 38) 
Reasons why women engaged in non-pleasurable sex were driven by a need to 
protect their partner and the relationship, but also to protect themselves from 
unwanted consequences.  
Protecting one’s self. 
Women revealed how they chose to be silent about their experiences as a self-
defence strategy to protect themselves from potentially negative consequences. Two 
women described how they chose not to communicate with their partner for fear their 
partner’s reaction would lead to unwanted consequences:  
I suppose there’s a small fear that he would say “Oh go off those 
antidepressants that’s crap.” You know, “You shouldn’t have to deal with it, go 
off them.” But the thing is, is that I’m getting so many good benefits, and I don’t 
want to yet, but I am planning to eventually.  (Mandy, 38) 
If I speak to him, how do I put this? He’s a typical truck driver – you know, take 
a spoon of concrete and “Harden the Fuck Up’. If they’re (the medication) doing 
that to you, just come off them. Of course, I can’t do that. (Charlotte, 45) 
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Women often emphasised the importance of sex within their relationship, and 
mentioned the need to hide their sexual difficulties for fear they would illuminate 
other problems within their relationship or their partners would look elsewhere for 
sex:  
I think generally, that would be a fear of whether to communicate that issue 
[with my husband], ‘cause if you bring it up, you know, are they going to go 
elsewhere type thing. Do you know what I mean? Have affairs and stuff like 
that? (Mandy, 38) 
   
Suffering in silence, and the high levels of secrecy surrounding the use of SSRIs 
appeared to be fuelled by the perceived public stigma of mental health problems and 
fear of being discriminated against. Women talked about being able to protect 
themselves from the negative public image of mental health problems and the 
ramifications in terms of their daily interactions and experiences. In Phoebe’s case, 
she applied corresponding stereotypes and prejudices to herself when explaining her 
reluctance to communicate with others: 
It’s not something you go “Hi, how’re you? I’m on anti-depressants”. You know 
people will turn and walk the other way and go “Well you’re screwed or 
something” - that’s what they think - like you’re an axe murderer or something. 
(Phoebe, 40) 
 
Trying to resolve 
 The theme trying to resolve included self-help strategies aimed at trying to fix or at 
least minimise sexual side effects of SSRIs. Sub-ordinate themes included altering 
medication, communicating with partner and taking steps to enhance sexual 
pleasure. All women, with exception of one, attempted to fix or at least try to resolve 
the problem and increase sexual pleasure; however, the type of approach was 
strongly influenced by length of time on medication. Women who had been on the 
medication for longer than two years used a combination of three approaches.  
 
Altering the medication 
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For women who had been on medication for more than two years, altering the 
medication was identified as one of the major strategies. Many women adopted a 
self-help approach to altering the medication, using a range of different strategies 
including, taking drug holidays (a brief period where the woman stops taking the 
SSRI to regain sexual feelings), reducing the dosage and quitting the medication in 
an attempt to restore sexual feelings. Julie said:   
I’ve resigned to the fact that, it’s almost like being on par to being a diabetic, I 
need the insulin to just keep functioning on a day to day basis and, um (pause) 
um, and yeah, it’s also led me to play with the dosage as well and try and 
decrease it so I can get some sexual function back, um, yeah. (Julie, 44) 
Nadia described how she stumbled across this strategy and highlighted how she 
successfully self-managed her dosage of medication to suit her particular situation: 
I forgot to bring my pills with me, and I started to experience really strong 
sexual dreams, and I almost like had an orgasm, it woke me up and I thought 
“oh” I’ve got these sexy feelings back again that’s really weird. So I guess I 
figured on my own that if I stopped taking the medication for a couple of days 
those sexy feelings would come back again. No one told me about this, but 
then again no one told me about the sexual affects either. So I kind of cottoned 
on to this idea that if I have a bit of a break then I’m more likely to have an 
orgasm or for sex to be more pleasurable. So I guess now what I do is I guess 
try to anticipate when we might be more likely to have sex and I just stop taking 
the medication a couple of days before. (Nadia, 42) 
Other women disagreed with the idea of self-managing their medication, highlighting 
the importance of taking the medication correctly and citing the fear of a relapse as a 
major reason for not altering the medication. This was the case even if they believed 
this strategy could work for them: 
 I did hear that you could take a few days off on some of them[ medication], I 
just wouldn’t, couldn’t even think about that, no way, I mean this sucks, but it 
does work and there’s just no way I ever want to risk get back to where I was. It 




Communicating with partner 
 
In contrast to the theme suffering in silence, some women on medication for more 
than two years, communicated with their partner about the sexual difficulties they 
were experiencing to resolve their sexual problems after other coping strategies had 
been attempted. For these women, communication with their partner was identified 
as being a necessary component of a longer-term coping strategy:  
It really does, um get in the way of your relationship and um, yeah it does.  You 
do have to talk a lot about it and you do have to communicate with your partner 
about it. ...and get across to them that it’s not them, it’s you, it’s these pills.  It’s 
yeah, it’s not them, they’re not less physically appealing or less effective in the 
bedroom, yeah. (Julie, 44) 
 Lisa, who described how she finally opened up and started to communicate about 
both her mental health problems and the associated side effects of the medication, 
echoed this point. In her case, communication was triggered by a major depressive 
episode: 
So it wasn’t until I hit the ground in December last year where I went off the 
medications and then I had a massive terrible episode, I nearly ended up in 
hospital and then obviously he saw me.  Like he saw me, he saw the deal, we 
saw what I was like and I honestly thought he was going to dump me but he 
didn’t.  He was fantastic, and that’s when after that I’ve been more open with 
him about it. It's only the past 3 months I've been this open about the 
medication, how it wipes out the sex feelings, the everything really, but it has 
been so much better since I’ve been open. (Lisa, 44) 
Taking steps to enhance sexual pleasure 
The women commonly reported their desire to experience sexual pleasure again; 
however, they recognized that sustained efforts were needed to make this happen. 
Women sought to enhance pleasure by using sex toys, pornography, masturbation, 
changing sexual positions and trying herbal supplements. For some women, sexual 
18 
 
difficulties were considered to be a shared problem rather than the woman’s 
problem; hence, this was a strategy that involved open and honest communication 
and cooperation between both partners: 
Um, I don’t know, I think in our case or my case I’ve just become more aware of 
what does really work for me, the big points that work for me, so I suppose not 
being afraid to (pause) use sex toys, pornography or anything else that 
particularly works for me. Um, (pause) you know and because my partner is 
aware, he doesn’t feel that it’s um, his failure, it’s just that this is what we have 
to do at the moment to make it work. So we do that. (Tahlia, 26) 
For other women, the search for sexual satisfaction involved trying to resolve the 
issue on their own: 
Um, well I guess this is a bit uncomfortable to talk about but, you know there 
are certain positions where I know I can reach orgasm much quicker and easier 
so I kind of move my body into that position, you know, and it does work 
sometimes. (Alison, 29) 
I did search on the internet for potions and supplements and stuff – I even 
bought Horny Goatweed, that Gingko Biloba is meant to work for sexual 
problems too, but you have to take a lot of it I think. (Lisa, 44) 
 
Accepting what is 
 
A further theme, particularly amongst women who had been on medication for over 
two years, related to acceptance of their particular situation. This theme included  
three sub-ordinate themes  i) counterbalancing the positive and negatives of SSRIs 
ii) embracing the positives in the relationship and iii) altering expectations about how 
sex ‘should be’. Sub-ordinate themes two and three were more commonly used as a 
strategy by women in longer- term relationships. Acceptance did not imply that the 




 I don’t see this getting any better so I don’t think there is going to be a magic 
solution, I really don’t believe there is going to be a pink Viagra or a pill that 
we are going to be able to pop that makes everything better.  I’d love to think 
there would be and that would give other women and myself something to 
look forward to.  I don’t think that’s gonna happen but every now and then I do 
jump onto Google in case there is something new on the market that might 
help. In terms of how I cope overall though, I guess I focus on the positives in 
my relationship and what’s working well and what’s good. (Nadia, 42)  
 
Counterbalancing the positive and negatives of SSRI medication 
Women in the study acknowledged the benefits from the medication, and although 
the sexual side effects were problematic, at least two women chose to focus on 
benefits:  
Sex isn’t as enjoyable as it was before I was on it [the SSRI] but I’m actually 
feeling better, like I’m feeling well so I kind of balanced it I guess you know with 
kind of going well yeah this side effect does really suck but look at what I’m 
gaining as well. (Alison, 29) 
In terms of coping, I think um, just um, acceptance is the thing that works for 
me the most, yeah. The medication has worked wonders for me, after my 
attempted suicide, well.... I don't want to go there again you know so the sex 
stuff, well I kind of just deal with it. (Julie, 44)  
Others highlighted how sex had been relegated as less important, while they focused 
on recovering from either anxiety or depression. There appeared to be a high level of 
acceptance that the medication would have positive and negative outcomes 
associated with it: 
I guess you have to sort of accept that you aren't going to have great sex...well 
you have to accept that I think. I think there’s no alternative, I think, you know 
well what are you gonna do? Stop the medication altogether? Well that’s not 
the right thing to do is it, I mean that stuff works.... it keeps me sane do you 
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know what I mean? So you have to, you have to just take the positives with the 
negatives don’t you? (Phoebe, 40) 
 
Embracing the positives in the relationship  
As part of an ongoing coping strategy, women in longer-term relationships described 
how they had started to focus on positives within the relationship, particularly the 
relational aspects of sexuality such as companionship and intimacy, rather than the 
physical act of sex. Mandy stated:  
I'm lucky, I guess, I actually get a lot out of just cuddling and kissing and being 
affectionate and the big thing that we always hear about is you know when the 
man puts the garbage out, you know I love all that stuff (both laughing). You 
know he’s been home the last week and he’s been making breakfast every 
morning and I find that really just wonderful. And to me that’s more than sex. 
(Mandy, 38) 
Similarly, Phoebe noted:    
At the end of the day, the sex you know, only goes for what minutes? But it’s 
that other stuff, hugging, intimacy, talking, helping each other - there’s all that 
sort of stuff happening which is still really important for both of us. (Phoebe, 40) 
 
Altering expectations about how sex ‘should be’ 
 
The women in this study discussed how they lowered their expectations about sex, 
and used positive self-talk to challenge social and cultural expectations of what sex 
should be like: 
I guess I have a tendency to think back to how it was in my 20’s and how 
amazing it was. And maybe that’s not realistic, even when you’re not on 
Aropax. I mean, how many of my 41 year old friends are having amazing sex, 
hanging from the chandeliers and multiple orgasms three times a week? Just 
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not happening, I don’t think, you really need to just accept that I guess. 
(Nadia, 42) 
Sonia  commented how her and her partner’s expectations about sexual frequency 
were altered as a result of their current circumstances. She also used positive self-
talk:   
When I had brought up the topic to with him [about the infrequency of sex], he 
just said “Oh well this is how it is now with the kids and..” yeah, so I suppose 
we’re kind of just accepting that this is how it is, and how it would be, even if I 
wasn’t on medication.  (Sonia, 30) 
Discussion 
Managing and treating the sexual side effects of SSRIs have presented a challenge 
to women, clinicians/ health professionals and researchers; to our knowledge, this is 
the first qualitative study to investigate how women cope with such side effects. Four 
discrete but overlapping super-ordinate themes emerged during analysis i) 
searching, ii) suffering in silence, iii) trying to resolve and iv) accepting what is. 
Women’s experiences of coping with sexual difficulties were similar to those reported 
by Mitchell, King, Nazareth & Wellings (2011), that both men and women manage 
sexual difficulties by using a number of coping strategies simultaneously but a 
combination that varied over time. The choice of coping strategy for women in this 
study was commonly influenced by the length of time on medication, the partnership 
context and external influences, particularly the socio-cultural context of their 
experiences. Consistent with findings from other studies  into female sexual 
difficulties (Ayling &Ussher, 2008; Holt & Slade, 2003; Marriott & Thompson, 2008), 
difficulties experienced by women in this study carried personal and relational 
meanings which impacted on their self-identity and influenced the type of strategies 
employed to cope with side effects.  
Whilst coping strategies have been classified in a number of different ways 
(Brandtstadter & Renner, 1990; Suls & Fletcher, 1985, Lazarus and Folkman, 1984), 
the strategies employed in this study, fit well with the two broad coping classes put 
forward by Lazarus and Folkman (1984), namely, problem and emotion-focused 
coping. Problem-focused coping involves efforts to alter the situation or 
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circumstances; in this study, the efforts included the strategies of ‘searching’ (for 
information and validation) and ‘trying to resolve’ (the problem). Whilst problem-
focused coping strategies are considered to be adaptive or associated with positive 
coping actions (Levahot, 2012), the debate about whether a strategy is adaptive or 
not is contested.  Indeed, studies have argued that all strategies potentially have an 
adaptive purpose (Bergvik, Sorlie & Wynn, 2010; Mitchell et al., 2011). Emotion-
focused coping, on the other hand, involves efforts to manage emotional rather than 
physical distress associated with the situation or circumstance, and tends to include 
both active (generally perceived to be adaptive) and avoidant strategies (considered 
to be maladaptive or detrimental) (Levahot, 2012). In this study, emotion-focused 
coping comprised the active strategy of ‘accepting what is’ and the avoidant strategy 
of ‘suffering in silence’. Although avoidant approaches (faking orgasm, avoiding 
sexual encounters, not communicating with partner) could typically be labelled as 
maladaptive, the findings revealed they did serve an adaptive purpose for those 
women who were on medication for two years or less.  
 
Searching  
The theme searching was identified as a key coping strategy in this study; women 
frequently reported that they searched for both information and validation to help 
make sense of their experience and to interpret their situations. This finding is 
consistent with other studies which have focused on living with an intimate problem 
which impacts upon female sexuality (Holt & Slade, 2003; Marriot & Thompson, 
2008). Once women had an explanation and could attribute their difficulties to SSRI 
medication, they reported feeling relieved and more capable to adjust to the sexual 
side effects. This finding corroborates the ideas of Happell, Manias and Roper 
(2004), who highlighted how individuals with mental health problems want to know 
about side effects from their medication in order to be better prepared. It also 
supports later research by Bahrik and Harris (2009), and Quinn, Happell and Browne 
(2012) that called for individuals to be better informed about the sexual side effects 
of antidepressants given their pervasiveness and potential to impact upon treatment 
and quality of life. Indeed, Mitchell and Selmes (2007) suggested that increased 
knowledge about side effects of medication may improve adherence rates in 




 Suffering in Silence  
The theme suffering in silence included three strategies and the idea that 
relationships were at risk, was central to those selected. The sub-ordinate themes of 
protecting one’s partner and protecting one’s self were identified by Hinchliff, Gott 
and Wylie (2012), who reported that women with sexual difficulties used strategies to 
avoid sexual encounters to protect their partner from the disappointment of being let 
down but also to protect themselves from the consequences associated with actively 
rejecting their partner. Social scripts privileging men’s wants and needs in a sexual 
relationship also strongly impacted most of the strategies used by the women in this 
study, particularly with respect to suffering in silence when they reported faking 
orgasm, avoiding sexual encounters and choosing not to communicate with their 
partners. Whilst individualistic and reductionist approaches to women’s sexual 
difficulties have been critiqued (Cacchioni & Tiefer, 2012; Tiefer, 2012), the women 
in this study attributed their sexual difficulties to SSRI medication, and viewed the 
problem as their ‘own problem’ as opposed to a shared problem. This is not 
surprising given the current biomedical approach to female sexual problems, which 
emphasises the importance of individual factors and ‘renders the complexity of 
factors affecting women’s sexual lives less visible’ (Nicholls, 2008, p. 516; Tiefer, 
2012). 
Our findings concur with studies that argue the socially constructed nature of 
women’s sexuality, and highlight the dominance of the male sexual drive discourse 
in Western culture (Ayling & Ussher, 2008; Davison & Huntington, 2010). The 
findings further our understanding of how social and cultural factors, such as 
dominant discourses of sexuality can influence how women cope with sexual side 
effects of SSRIs.  Additionally, reluctance to communicate with their partner and 
others also featured prominently, and the women talked about how the perception of 
public stigma relating to mental health problems and/or a sexual problem led them to 
suffer in silence. Prior studies have noted that individuals with a stigmatised 
condition have been more likely to self-manage information or, to at least assess the 
costs and benefits of disclosure to others, citing risk, embarrassment and impact on 
social identity as key factors (Davison & Huntington, 2010; Goffman, 1963; Holt & 





Trying to Resolve  
Women on long-term medication frequently attempted to resolve sexual difficulties. 
Women attempted to self-manage the problem and did not seek help or report it to a 
clinician, therapist or health professional because of previous inadequate help-
seeking experiences, and embarrassment about the sensitive nature of sexual 
difficulties. This finding supported the work undertaken by Rosenberg, Bleiberg, 
Koscis and Gross (2003) which reported that 80% of women with mental health 
problems did not seek formal help for sexual side effects of medication. Despite the 
sexual side effects, women in this study continued to take their medication. However, 
those women on longer-term medication altered the dosage or took a drug holiday in 
an attempt to restore sexual feelings, which are consistent with strategies reported 
through biomedical research aimed at managing sexual side effects (Clayton & 
Balon, 2009; Schweitzer, Maguire & Ng, 2009). 
 Although switching antidepressant medication has been highlighted by 
Baldwin (2004) and Clayton and Balon (2009) as a legitimate strategy to help 
manage antidepressant related sexual difficulties, surprisingly, none of the women in 
this study considered this to be a realistic strategy. Our findings revealed that women 
made a conscious decision to continue their prescribed medication highlighting the 
perceived benefits and fear of potential relapse, which supports the work by Clayton 
and Balon (2009) that reported individuals might be fearful of therapeutic failure with 
a new drug. Other sub-ordinate themes aimed at trying to resolve the problem 
included communicating with their partner and taking steps to enhance sexual 
pleasure. Although prior studies have highlighted how increased communication with 
a partner has positively impacted how women cope with sexual difficulties (Hayes, 
2008; Mitchell et al., 2011), it was somewhat surprising that the women on 
medication for less than 12 months in this study chose not to communicate with their 
partner. This was a deliberate strategy to protect both their partner and themselves.  
 
Accepting What Is 
 For women on long-term medication, acceptance of their situation helped them to 
cope with the sexual side effects. Attempts to embrace the positives within their 
relationship and to change expectations about sex were commonly employed, 
findings, which support the study on coping with sexual, side effects conducted by 
Mitchell et al. (2011). These two coping strategies fit with the ‘Good Enough Sex 
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Model’ proposed by Metz and McCarthy (2007), which encourages positive and 
realistic expectations about the role and meaning of both intimacy and sexuality 
across the lifespan. Proponents of this model argued such a perspective can provide 
a positive and genuine foundation for relationship and sexual satisfaction (McCarthy 
& McDonald, 2009; Metz & McCarthy, 2007). Our findings also support calls by other 
researchers to consider a therapeutic approach to managing female sexual 
difficulties, an approach based on questioning and challenging rigid sexual scripts 
and normative heterosexual practices (Farrell & Cacchioni, 2012; Mc Cormick, 2010; 
Mitchell et al., 2011).  Consistent with findings from Sutherland’s (2012) study into 
women’s experiences of sexual pain and discomfort, the women in this study had not 
given up hope that their situation would eventually improve; indeed those who 
employed acceptance as a coping strategy also continued to search for information 
in the hope of finding a solution. 
 
Implications and Limitations 
Implications  
The findings from our study have practical implications for women on SSRIs and for 
clinicians, therapists and health professionals, and provide further insight into the 
types of strategies that could be promoted to women in order to improve the success 
of and satisfaction with SSRI treatment. Our findings call for open and proactive 
communication between clinicians/health professionals and women with respect to 
sexual side effects, and highlight the importance of having sexual concerns validated. 
An authentic commitment is needed to ensure that clinicians, therapists and health 
professionals have the necessary education and skills to work effectively with 
women to enhance the management of sexual difficulties; the authors suggest such 
issues are highlighted by relevant professional associations and included in 
professional development programs. It is also evident from this study that women’s 
lack of knowledge relating to the sexual side effects of SSRIs impacted on their 
ability to cope. It is imperative, therefore, that information materials, which outline 
sexual side effects and common concerns, be developed and made available in a 
variety of formats.   
Our findings also emphasise the need to recognise and address 
psychological, social and cultural factors, which may have an influence on how 
women cope with sexual side effects. Effective management of SSRI related sexual 
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difficulties calls for a collaborative approach, which moves beyond biomedical 
interventions relating to the treatment of sexual difficulties. A psychological 
intervention, which recognises the influence of social and cultural context on 
women’s experiences, may be effective in helping individual women to work through 
the influence of context on their experience, explore multiple meanings they may 
have around sex and help develop a positive sense of themselves as women. Such 
an approach also needs to be complemented by couple therapy, which explores 
relationship dynamics and how best to work with them to achieve mutually satisfying 
outcomes within the relationship. Understanding the complex interaction among the 
various psychological, cultural and social factors is essential for helping women to 
effectively manage the sexual difficulties associated with SSRIs and to ultimately 
improve treatment outcomes.  
Limitations 
The limitations to this study include the relative homogeneity and self-selected 
nature of the sample. The women in the study were purposefully selected to ensure 
a degree of homogeneity and to enable us to explore the phenomenon of coping with 
SSRI related sexual difficulties across a particular target group (heterosexual, in a 
relationship, under 45 years old). Hence, the findings cannot be generalised to all 
women who experience SSRI related sexual difficulties. Indeed, the diverse age 
range of women in the study (23 to 45 years) further limits this study, as the potential 
differences in sexual experiences across the lifespan were not addressed. 
Furthermore, it is also probable the women who chose to participate in the study had 
reached a stage of adjustment, as they were willing to talk openly about their coping 
experiences. Women who were struggling to cope may not be represented here. 
The researchers recognise that this study does not represent the experiences of all 
women who experience SSRI related sexual difficulties; however, the purpose was 
to provide a detailed exploration of experiences from individual perspectives.  
 
Conclusion 
This study has captured the shared elements and unique voices of women who are 
coping with the sexual side effects of SSRI medication and has situated their 
experiences within a social and cultural context. It has provided an insight into what 
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coping strategies women use, factors influencing choice of coping strategy,  and how 
women use different strategies to manage the sexual side effects of SSRIs. 
Furthermore, it has illuminated the importance of contextualising these difficulties as 
part of an overall approach to improve the management and treatment of these 
sexual side effects.  
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